Fund HoldingsLynx1 Capital Management LP

Total Portfolio Value
$254.32M
Total Bought
$96.14M
Total Sold
$19.01M
Net Transaction
+$77.13M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
ALPINE IMMUNE SCIENCES INC2,404,6143,813,926+1,409,31227,53372,69328.58%+45,161
TSCAN THERAPEUTICS INC5,224,6005,224,600013,37530,45911.98%+17,084
CABALETTA BIO INC2,106,0002,110,401+4,40132,05347,90618.84%+15,853
C4 THERAPEUTICS INC1,019,2303,134,396+2,115,1661,89617,7096.96%+15,814
STOKE THERAPEUTICS INC(STOK)1,710,1542,956,918+1,246,7646,73815,5536.12%+8,815
AUTOLUS THERAPEUTICS PLC1,363,0251,858,409+495,3843,17611,9684.71%+8,792
MERUS N V1,150,2251,135,225-15,00027,12231,21912.28%+4,096
KINNATE BIOPHARMA INC1,997,0061,997,00602,7964,7331.86%+1,937
SILENCE THERAPEUTICS PLC235,787235,78702,3154,0961.61%+1,780
THESEUS PHARMACEUTICALS INC702,415702,41501,8892,8451.12%+955
PASSAGE BIO INC190,124379,159+189,0351253830.15%+258
NEKTAR THERAPEUTICS(NKTR)1,766,8151,929,198+162,3831,0521,0900.43%+38
DBV TECHNOLOGIES S A18,2650-18,265250-25
ZURA BIO LTD9,9170-9,917650-65
GH RESEARCH PLC(GHRS)1,103,1781,838,617+735,43911,08710,6644.19%-423
BIONOMICS LIMITED815,512824,305+8,7932,2021,2200.48%-982
PIERIS PHARMACEUTICALS INC9,775,8499,775,84902,9131,7790.70%-1,134
CYMABAY THERAPEUTICS INC994,1610-994,16114,8230-14,823
Page 1 of 1